| Zoetis is a holding company. Through its subsidiaries, Co. is engaged in the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. Co.'s segments are: the U.S. and International. Co.'s main product categories are: vaccines, anti-infectives, parasiticides, dermatology products, other pharmaceutical products, medicated feed additives, and animal health diagnostics. Co.'s other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services in biodevices, genetic tests and precision livestock farming. |
When researching a stock like Zoetis, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ZTS Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ZTS stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the ZTS 200 day moving average ("ZTS 200 DMA"), while one of the most popular "shorter look-backs" is the ZTS 50 day moving average ("ZTS 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Zoetis.